Novel cardiopulmonary exercise testing variables to differentiate neuromuscular deconditioning from disease
新型心肺运动测试变量可区分神经肌肉功能失调与疾病
基本信息
- 批准号:10736044
- 负责人:
- 金额:$ 75.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AbdomenAcuteAerobicAffectBiopsyBlood PressureBlood VesselsCardiopulmonaryCardiopulmonary PhysiologyCardiovascular AbnormalitiesCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCaringCell RespirationChestChronic DiseaseChronic Obstructive Pulmonary DiseaseClinicalClinical assessmentsDataDiagnosisDiagnosticDiseaseDisease ProgressionDual-Energy X-Ray AbsorptiometryDyspneaEFRACEchocardiographyEducationElderlyElectrocardiogramEnrollmentEquationEquipmentExerciseExercise TestExercise ToleranceFatigueFunctional disorderGasesGuidelinesHealth systemHeart DiseasesHeart TransplantationHeart failureIndividualInterruptionInterventionIsotonic ExerciseLegLife ExpectancyLungMeasurementMeasuresMonitorMorphologyMuscleMuscle WeaknessMuscular AtrophyNeuromuscular DiseasesNormal RangeNormalcyOperative Surgical ProceduresOutcomeParticipantPatientsPerformancePeripheralPopulationPostoperative PeriodPrognosisPropertyProtocols documentationPublishingPulmonary Gas ExchangePulse OximetryRaceReference ValuesRehabilitation therapyReproducibilityRestSamplingSensitivity and SpecificitySeveritiesSkeletal MuscleSpecificitySpeedStratificationStressSystemTechnologyTestingTherapeuticThinnessTrainingTraining ProgramsTranslatingTriageWomanWorkage stratificationagedclinical decision-makingclinical practiceclinical prognosticdeconditioningdemographicsdiagnostic valuedisease prognosisexercise intoleranceexercise trainingexperienceheart preservationhemodynamicsimprovedindexinglaboratory experimentmalemanufacturing testmenmuscle formneuromuscularneuromuscular functionneuromuscular systemnovelpredictive modelingpreservationpulmonary functionreduced muscle massresponserisk stratificationsex
项目摘要
PROJECT SUMMARY
Cardiopulmonary exercise testing (CPET) is an objective, non-invasive, measure of the integrated function of
the pulmonary, cardiovascular and neuromuscular systems. CPET evaluates submaximal and peak exercise
responses, informing on causes of dyspnea and/or fatigue, disease prognosis and/or progression, pre- or post-
surgical risk stratification, or exercise training prescription. Clinical use of CPET is estimated to have increased
by 81% between 2005 and 2015. The most common problem for CPET interpretation is discriminating between
cardiovascular disease and neuromuscular deconditioning e.g., low muscle mass, weakness and/or fatigability.
We have developed a solution to this problem, using a modified CPET with integrated isokinetic (IK)
measurements of muscle power, which independently assesses neuromuscular performance without
affecting measurement of standard CPET variables. The modified CPET adds <10min to the standard CPET
and uses commercially available equipment. The modified CPET produces 4 new IK variables: 1) Baseline peak
isokinetic power: deconditioned muscles are weak; 2) Tolerance index: the fraction of peak IK power at
V̇O2peak. Aerobic deconditioning reduces the available peak IK power that can be supported by aerobic
metabolism; 3) Fatigue index: The loss of peak IK power for a given work rate. Aerobic deconditioning increases
fatigability; 4) Power reserve: The capacity for acute power increase at V̇O2peak. A power reserve indicates that
neuromuscular performance is not limiting to exercise tolerance. The modified CPET is reproducible and well
tolerated by elderly, normal subjects and athletes, and those with heart failure or COPD. The modified CPET
can differentiate neuromuscular deconditioning as a cause of exercise limitation from cardiovascular or
pulmonary limitations (assessed by standard CPET). To inform clinical interpretation, this project will develop
predictive models describing normal reference values for IK variables in men and women aged 18-80yr.
Threshold values of neuromuscular performance (with corresponding sensitivity and specificity) will be
developed and optimized to discriminate a deconditioned population. Variables that moderate neuromuscular
performance measures associated with deconditioning will be identified (e.g. V̇O2peak, diastolic dysfunction,
vascular reactivity, leg lean mass, leg strength and power, muscle oxidative capacity and muscle biopsy
morphology). Finally, the discriminative ability of IK variables for deconditioning will be tested by measuring
sensitivity of IK variables in response to exercise training in deconditioned individuals and the specificity of IK
variables to discriminate peripheral vs. central hemodynamic exercise limitations using invasive CPET in patients
with heart failure and preserved ejection fraction. This study will transform the utility and diagnostic capabilities
of CPET and improve clinical decision-making and severity stratification across a wide range of chronic disease
states where deconditioning is a common feature.
项目摘要
心肺运动测试(CPET)是客观的,无创的,衡量的综合功能
肺,心血管和神经肌肉系统。 CPET评估次最大和高峰锻炼
回答,了解呼吸困难和/或疲劳的原因,疾病进展和/或进展,前或之后
手术风险分层或运动训练处方。估计CPET的临床用途已增加
在2005年至2015年之间,达到81%。CPET解释的最常见问题是区分
心血管疾病和神经肌肉衰减,例如低肌肉质量,无力和/或疲劳性。
我们使用具有集成的同动剂(IK)的修改后的CPET开发了解决此问题的解决方案。
肌肉力量的测量,可独立评估神经肌肉性能
影响标准CPET变量的测量。修改后的CPET向标准CPET添加了<10分钟
并使用市售的设备。修改后的CPET产生4个新的IK变量:1)基线峰
同动力:肌肉弯曲的肌肉很弱; 2)公差指数:峰值IK功率的比例
vïo2peak。有氧运动降低了可用的峰值IK功率,该功率可以由有氧运动支持
代谢; 3)疲劳指数:给定工作率的IK峰值功率损失。有氧运动增加
疲劳; 4)动力储备:VİO2PEAK时急性功率增加的能力。动力储备表明
神经肌肉性能并非限制运动耐受性。修改后的CPET可再现且很好
由老年人,正常的受试者和运动员以及心力衰竭或COPD的运动员容忍。修改后的CPET
可以区分神经肌肉缩减作为导致运动限制的原因与心血管或
肺部局限性(通过标准CPET评估)。为了告知临床解释,该项目将开发
描述18-80岁男性和女性IK变量正常参考值的预测模型。
神经肌肉性能的阈值(具有相应的灵敏度和特异性)将是
开发和优化以区分被污染的人群。现代化神经肌肉的变量
将确定与调节性相关的性能指标(例如,vïo2peak,舒张功能障碍,
血管反应性,腿部质量,腿部强度和力量,肌肉氧化能力和肌肉活检
形态学)。最后,将测量IK变量对结论的判别能力进行测试
IK变量响应于decondientition的个体的运动训练和IK的特异性的敏感性
使用患者使用侵入性CPET区分外围与中央血液动力学局限性的变量
具有心力衰竭和保留的射血分数。这项研究将改变效用和诊断功能
CPET并改善各种慢性疾病的临床决策和严重性分层
调节是一个共同特征的状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harry B Rossiter其他文献
Harry B Rossiter的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10316205 - 财政年份:2019
- 资助金额:
$ 75.74万 - 项目类别:
Mechanisms of aortopathy in LRP1 deficiency
LRP1 缺乏导致主动脉病的机制
- 批准号:
10066364 - 财政年份:2019
- 资助金额:
$ 75.74万 - 项目类别: